eNews
Home page > Comments


Comments

Amgen pancreatic cancer drug lacks efficacy, trial ends

09.08.2012. | (Reuters) - Amgen Inc halted a late-stage trial of an experimental drug for pancreatic cancer after independent reviewers concluded that it was unlikely to significantly help patients....


Оставите Ваш коментр
*Име:

Е-пошта:


*Ваш коментар:
:) :D ;) B-) :P :-o :( x-(

*Сигурносни број: